Journal profile

Oncology

Publisher: MultiMedia Healthcare
ISSN0890-9091 FormatPrint StatusCurrently indexed
Official Website Verify CrossRef

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.42
Citation rate 1.28 72 total citations
h5-index 13 h5 depth signal
Cited share 51.7% 30 of 58
Total citations 72 Citation footprint
Metric signal 1.00 External metric anchor
Self-citation 0.0% 0 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 101
Mexico 12
China 5
Japan 4
Spain 3

Citing Fields of Research

Oncology 99
Lymphomas 42
Lung Cancer 31
Prostate Cancer 26
Immunology 24

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 284 Articles tracked across the journal lifetime
Indexed publication set 58 30 cited publications
Last 12 months 29 3.6 publications/month
Open access share 0.0% 0 OA publications in the last year
Leading citing country United States 101 citing publications
Leading citing field Oncology 99 citing publications
Latest tracked publication 22 July 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, Mar. 1987-
PubMed
v1n1, Mar. 1987-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Lymphomas Oncology Immunology Breast Cancer Palliative Care Hematology

Broad Categories

Neoplasms Lymphomas Urology Hematology Liver & Colon Cancer Gut-Brain Axis Disorders Breast Cancer Immunology

MeSH Descriptors

Medical Oncology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Open DOI
José Luis Rodríguez-Olivares, Mauricio Mora Pineda, Evelyn L. Beas Lozano et al.
PURPOSE: Metastatic prostate cancer treatment has evolved in the past few decades, finding targeted therapy in the homologous recombination repair (HRR) pathway and mismatch repair (MMR) deficiency. METHODS: This cross-sectional study ev...
03
Open DOI
Irgen Tafaj, Oksana Allko, Liri Cuko
We describe a unique clinical case of primary melanoma of the ascending colon presenting with intussusception and profuse hemorrhage. A 72-year-old man on anticoagulant therapy was admitted with massive rectal bleeding and hypotension. C...
06
Open DOI
Carmel Awadallah, Anas Zayad
Background : Bispecific T-cell engagers (BiTEs) and chimeric antigen receptor (CAR) T-cell therapies have transformed the management of hematologic malignancies, including relapsed/refractory multiple myeloma (RRMM), lymphomas, and leuke...
07
Open DOI
Michał Kostrzanowsk, Adam Górski, Grzegorz Panek et al.
The term synchronous refers to 2 or more primary independent malignancies, when the second (or subsequent) arises within 6 months after diagnosis of the first malignancy. Synchronous endometrial and ovarian cancers are found in 10% of pa...
09
DOI 10.46883/2026.25921074

Before Certainty

Open DOI
Yan Leyfman
The consult was a single word. Lymphoma. No question mark. No differential. No pause—just a diagnosis, written as certainty before it had earned the right to be one. He was 34.

Bibliographical & Catalog Notes

Title from cover.

Vol. 1 (1987) complete in 10 issues.

Supplements accompany some vols.

Also issued online.

19950523 Not printed on acid-free paper